For IL-4, we found no effects of treatment, we did however find that the levels of this cytokine were higher in females than males (main effect of sex: F (1,48) = 6.954, p 2 = 0.127, p = 0.011
No statements anywhere on this website have been evaluated by the FDA
[31] but contradicts Thomas et al.s finding that increased LPCs and SM corresponded to more favorable outcomes at 6 months [31]
This stratified approach avoids the one-size-fits-all assumptions that have constrained past indication extension attempts and provides a clearer, evidence-led path to expanding GLP-1 use where it is biologically and clinically justified.
Choose glycinate for sleep and general tolerance, citrate when constipation is the target
Single-compound peptide: PT-141 (Bremelanotide) 10mg